REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $14,721,000 | -25.5% | 850,942 | -23.6% | 0.29% | -17.9% |
| Q1 2014 | $19,771,000 | -29.9% | 1,114,462 | -27.6% | 0.36% | -36.9% |
| Q4 2013 | $28,184,000 | +39.0% | 1,540,091 | +67.3% | 0.57% | +16.2% |
| Q3 2013 | $20,275,000 | -16.5% | 920,591 | -30.1% | 0.49% | -3.4% |
| Q2 2013 | $24,287,000 | +146.1% | 1,316,357 | +114.8% | 0.50% | +54.4% |
| Q1 2013 | $9,868,000 | – | 612,906 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,001,000 | $970,000 | 0.21% |
| Allegis Investment Advisors, LLC | 341,669 | $331,000 | 0.19% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $384,000 | 0.04% |
| Alambic Investment Management, L.P. | 114,591 | $111,000 | 0.04% |
| Gruss Capital Management LP | 600,000 | $582,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 102,086 | $99,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 323,429 | $314,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,931 | $27,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $3,000 | 0.00% |
| Airain ltd | 13,690 | $13,000 | 0.00% |